Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma

Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma

Abstract Multiple myeloma (MM) is an aggressive plasma cell neoplasm characterized by genomic heterogeneity. Superenhancers (SEs) are defined as large clusters of enhancers in close genomic proximity, which regulate genes for maintaining cellular identity and promote oncogenic transcription to which...

Full description

Bibliographic Details
Main Authors:	Yunlu Jia, Jianbiao Zhou, Tze King Tan, Tae-Hoon Chung, Regina Wan Ju Wong, Jing-Yuan Chooi, Julia Sze Lynn Lim, Takaomi Sanda, Melissa Ooi, Sanjay De Mel, Cinnie Soekojo, Yongxia Chen, Enfan Zhang, Zhen Cai, Peng Shen, Jian Ruan, Wee-Joo Chng
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-02-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-021-00421-7

Similar Items

Immunotherapy in Multiple Myeloma
by: Cinnie Yentia Soekojo, et al.
Published: (2020-03-01)

Potential Clinical Application of Genomics in Multiple Myeloma
by: Cinnie Yentia Soekojo, et al.
Published: (2018-06-01)

Natural History and Prognostic Factors at First Relapse in Multiple Myeloma
by: Chen Wang, et al.
Published: (2020-07-01)

Stem-cell transplantation in multiple myeloma: how far have we come?
by: Cinnie Y. Soekojo, et al.
Published: (2019-11-01)

Implications of Heterogeneity in Multiple Myeloma
by: Sanjay de Mel, et al.
Published: (2014-01-01)

STAT3: A Promising Therapeutic Target in Multiple Myeloma
by: Phyllis S. Y. Chong, et al.
Published: (2019-05-01)

MMSET: Role and Therapeutic Opportunities in Multiple Myeloma
by: Zhigang Xie, et al.
Published: (2014-01-01)

MicroRNA: Important Player in the Pathobiology of Multiple Myeloma
by: Chonglei Bi, et al.
Published: (2014-01-01)

CAR T-cell therapy in multiple myeloma: more room for improvement
by: Phaik Ju Teoh, et al.
Published: (2021-04-01)

Immunoglobulin M Paraproteinaemias
by: Louis-Pierre Girard, et al.
Published: (2020-06-01)

A unique rhinologic manifestation of multiple myeloma
by: Jun Jie Seah, et al.
Published: (2021-06-01)

A novel measure of chromosome instability can account for prognostic difference in multiple myeloma.
by: Tae-Hoon Chung, et al.
Published: (2013-01-01)

Determinants of sensitivity to DZNep induced apoptosis in multiple myeloma cells.
by: Zhigang Xie, et al.
Published: (2011-01-01)

NaviSE: superenhancer navigator integrating epigenomics signal algebra
by: Alex M. Ascensión, et al.
Published: (2017-06-01)

Targeting NF-kB Signaling for Multiple Myeloma
by: Ada Hang-Heng Wong, et al.
Published: (2020-08-01)

eRNAs and Superenhancer lncRNAs Are Functional in Human Prostate Cancer
by: Xiaona Zhang, et al.
Published: (2020-01-01)

Epigenetic silencing of long non-coding RNA BM742401 in multiple myeloma: impact on prognosis and myeloma dissemination
by: Zhenhai Li, et al.
Published: (2020-08-01)

Super-enhancers: critical roles and therapeutic targets in hematologic malignancies
by: Yunlu Jia, et al.
Published: (2019-07-01)

Targeted Therapies for Multiple Myeloma
by: Christopher Chang-Yew Leow, et al.
Published: (2021-04-01)

Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report
by: David L. Murray, et al.
Published: (2021-02-01)

Multiple myeloma with lung plasmacytoma
by: Rajendra Prasad, et al.
Published: (2011-01-01)

Multiple myeloma: Combination therapy of BET proteolysis targeting chimeric molecule with CDK9 inhibitor.
by: Su-Lin Lim, et al.
Published: (2020-01-01)

p53 Abnormalities and Potential Therapeutic Targeting in Multiple Myeloma
by: P. J. Teoh, et al.
Published: (2014-01-01)

Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion
by: Tracy King, et al.
Published: (2018-01-01)

Multiple myeloma
by: Larisa P. Mendeleeva, et al.
Published: (2021-02-01)

Multiple Myeloma
Published: (2021)

Renal Failure in Multiple Myeloma "The Myeloma Kidney":State of the Art
by: Goldschmidt Hartmut, et al.
Published: (2001-01-01)

Vinorelbine-Cyclophosphamide compared to cyclophosphamide in peripheral blood stem cell mobilization for multiple myeloma
by: Sanjay de Mel, et al.
Published: (2018-12-01)

Newly diagnosed multiple myeloma in Taiwan
by: Chung-King Lin, et al.
Published: (2009-07-01)

Multiple Myeloma An Overview
Published: (2012)

Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma
by: Efrat Markus, et al.
Published: (2020-05-01)

Multiple myeloma in Saudi Arabia: Consensus of the Saudi lymphoma/myeloma group
by: Ahmed Alaskar, et al.
Published: (2019-01-01)

Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy
by: Rajshekhar Chakraborty, et al.
Published: (2021-06-01)

Cellular immunotherapy in multiple myeloma
by: Manh-Cuong Vo, et al.
Published: (2019-09-01)

Hematuria in Multiple Myeloma
by: Ali Akbar Handjani, et al.
Published: (1965-01-01)

Myeloma and diabetes mellitus
by: Sora Yasri, et al.
Published: (2014-01-01)

Living With Multiple Myeloma
by: Leanne Monterosso PhD, BNurs(Hons), GCert Tert Teach, RN, RM, NNT, FACN, et al.
Published: (2018-03-01)

Progress in multiple myeloma
by: Reinhold Munker, et al.
Published: (2019-01-01)

Hematuria in Multiple Myeloma
by: Ali Akbar Handjani, et al.
Published: (1965-12-01)

Hypercoagulability in multiple myeloma
by: E S Urnova, et al.
Published: (2014-07-01)